Yahoo! Finance: BMY News

Five Holiday Dividend Increases (at Seeking Alpha)

Mon, 28 Dec 2009 14:23:25 Etc/GMT

Large-Cap Biotechs Face Familiar Problem (Investor's Business Daily)

Thu, 24 Dec 2009 22:59:44 Etc/GMT

It looks as if Big Pharma and Big Biotech shares have begun a period of role reversal.

Biggest changes in NYSE short interest (at Reuters)

Thu, 24 Dec 2009 22:10:37 Etc/GMT

European Health Care Approvals And Partnership With Drug Giant Novartis Cements This Stocks Rating As A Good Buy, According To Senior Portfolio Manager (Wall Street Transcript)

Thu, 24 Dec 2009 14:37:00 Etc/GMT

67 WALL STREET, New York - December 23, 2009 - The Wall Street Transcript has just published its GARP And Other Investing Strategies Report offering a timely review of the sector to serious investors and industry executives. This 59 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

5 Stocks That Give the Gift of Dividend Growth (at Seeking Alpha)

Thu, 24 Dec 2009 14:07:38 Etc/GMT

Wall Street Breakfast: Must-Know News (at Seeking Alpha)

Thu, 24 Dec 2009 12:19:32 Etc/GMT

Cramer's Stop Trading! Why the Housing News Is Good (12/23/09) (at Seeking Alpha)

Thu, 24 Dec 2009 11:58:03 Etc/GMT

BRISTOL MYERS SQUIBB CO Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Other Events, Financi (EDGAR Online)

Thu, 24 Dec 2009 11:07:41 Etc/GMT

Bristol-Myers Cuts 2009 Outlook (Zacks.com)

Thu, 24 Dec 2009 09:16:49 Etc/GMT

Bristol-Myers Squibb lowered its fiscal 2009 outlook as a result of the split-off of pediatric nutrition company Mead Johnson Nutrition Co.

Bristol-Myers spent $953K lobbying gov't in 3Q (AP)

Wed, 23 Dec 2009 23:35:45 Etc/GMT

Pharmaceutical company Bristol-Myers Squibb Co. spent $953,000 lobbying on drug pricing and access, health care and patent reform in the third quarter, according to a quarterly disclosure form.

BRISTOL MYERS SQUIBB CO Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia (EDGAR Online)

Wed, 23 Dec 2009 22:19:27 Etc/GMT

How These Companies Beat the Market (at Motley Fool)

Wed, 23 Dec 2009 20:55:14 Etc/GMT

Cramer: New-Home Sales Were Good - Here's Why (at CNBC)

Wed, 23 Dec 2009 20:44:00 Etc/GMT

Cramer's 'Stop Trading': Google, RIMM (at TheStreet.com)

Wed, 23 Dec 2009 20:15:32 Etc/GMT

Cancer Isn't Merck's Biggest Problem (at Motley Fool)

Wed, 23 Dec 2009 20:05:35 Etc/GMT

Bristol-Myers cuts outlook after Mead split (AP)

Wed, 23 Dec 2009 19:12:53 Etc/GMT

Drug developer Bristol-Myers Squibb Co. cut its 2009 profit outlook Wednesday after completing a split off of its Mead Johnson Nutrition Co. holdings.

A 'Day of Reckoning' Coming for S&P 500: Market Pro (at CNBC)

Wed, 23 Dec 2009 17:42:31 Etc/GMT

Bristol-Myers Parts Ways With Mead Johnson (at Minyanville.com)

Wed, 23 Dec 2009 16:30:00 Etc/GMT

After the spin-off, expect lower earnings.

Biotech Stocks: Drug stocks trade higher; Sanofi, Achillion gain (at MarketWatch)

Wed, 23 Dec 2009 15:51:00 Etc/GMT

Drug- and biotech-sector benchmarks move higher in early action, with Sanofi-Aventis and Bristol-Myers Squibb among the issues holding investors' attention.